Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | RO7444973 |
Synonyms | |
Therapy Description |
RO7444973 is a bispecific T-cell engaging antibody that targets MAGE-A4 and CD3, which potentially leads to activation and targeting of cytotoxic T-lymphocytes to tumor cells expressing MAGE-A4, resulting in tumor cell killing (NCI Drug Dictionary). |